Evaluation of the state of medical care in patients with arterial hypertension in combination with gout by retrospective analysis data.

The prevalence of cardiovascular diseases, especially arterial hypertension, continues to increase. An important problem is the management of the patient with a comorbid pathology in the primary link by the family physician. The purpose of this study was to assess the state of medical care in patien...

Full description

Saved in:
Bibliographic Details
Main Authors: A. P. Kuzmina, O. M. Lazarenko
Format: Article
Language:English
Published: Dnipro State Medical University 2019-01-01
Series:Medičnì Perspektivi
Subjects:
Online Access:http://journals.uran.ua/index.php/2307-0404/article/view/152987
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846095548403154944
author A. P. Kuzmina
O. M. Lazarenko
author_facet A. P. Kuzmina
O. M. Lazarenko
author_sort A. P. Kuzmina
collection DOAJ
description The prevalence of cardiovascular diseases, especially arterial hypertension, continues to increase. An important problem is the management of the patient with a comorbid pathology in the primary link by the family physician. The purpose of this study was to assess the state of medical care in patients with arterial hypertension combined with gout, using a retrospective analysis of ambulatory cards, diagnostic and treatment data. There were analyzed 105 outpatient cards that met the inclusion criteria. The mean age of patients was 53.5±10.2 years. Among the examined patients there were 99 males (94.3%), and 6 (5.7%)females. Аrterial hypertension stage II has been reported in 100 (95.2%) patients, stage III – 5 (4.8%) patients. Аrterial hypertension 1 degree is established in 74 (70,5%) patients, 2 degrees – 21 (20%), 3 degrees – 10 (9,5%). The average duration of the gout was 4.4 [4; 2] years, arterial hypertension – 5.3 [3; 1] years. Acute gouty arthritis was present in 11 (10.5%) patients, chronic gouty arthritis – 85 (81%), and chronic tofi arthritis – 9 (8.5%). Patients seek medical help from their family doctor too late. Examination of patients with hypertension in combination with gout is not complete, this contributes to underestimation of total cardiovascular risk. In a number of cases, titration of the dose of allopurinol higher than 300 mg is not, performed so only a third of patients reach the target uric acid level.
format Article
id doaj-art-e15cc7fd5da7427aa2e79e38d36ab836
institution Kabale University
issn 2307-0404
language English
publishDate 2019-01-01
publisher Dnipro State Medical University
record_format Article
series Medičnì Perspektivi
spelling doaj-art-e15cc7fd5da7427aa2e79e38d36ab8362025-01-02T10:23:23ZengDnipro State Medical UniversityMedičnì Perspektivi2307-04042019-01-01234161910.26641/2307-0404.2018.4.152987152987Evaluation of the state of medical care in patients with arterial hypertension in combination with gout by retrospective analysis data.A. P. KuzminaO. M. LazarenkoThe prevalence of cardiovascular diseases, especially arterial hypertension, continues to increase. An important problem is the management of the patient with a comorbid pathology in the primary link by the family physician. The purpose of this study was to assess the state of medical care in patients with arterial hypertension combined with gout, using a retrospective analysis of ambulatory cards, diagnostic and treatment data. There were analyzed 105 outpatient cards that met the inclusion criteria. The mean age of patients was 53.5±10.2 years. Among the examined patients there were 99 males (94.3%), and 6 (5.7%)females. Аrterial hypertension stage II has been reported in 100 (95.2%) patients, stage III – 5 (4.8%) patients. Аrterial hypertension 1 degree is established in 74 (70,5%) patients, 2 degrees – 21 (20%), 3 degrees – 10 (9,5%). The average duration of the gout was 4.4 [4; 2] years, arterial hypertension – 5.3 [3; 1] years. Acute gouty arthritis was present in 11 (10.5%) patients, chronic gouty arthritis – 85 (81%), and chronic tofi arthritis – 9 (8.5%). Patients seek medical help from their family doctor too late. Examination of patients with hypertension in combination with gout is not complete, this contributes to underestimation of total cardiovascular risk. In a number of cases, titration of the dose of allopurinol higher than 300 mg is not, performed so only a third of patients reach the target uric acid level.http://journals.uran.ua/index.php/2307-0404/article/view/152987hypertensiongouturat-lowering therapyantihypertensive drugs
spellingShingle A. P. Kuzmina
O. M. Lazarenko
Evaluation of the state of medical care in patients with arterial hypertension in combination with gout by retrospective analysis data.
Medičnì Perspektivi
hypertension
gout
urat-lowering therapy
antihypertensive drugs
title Evaluation of the state of medical care in patients with arterial hypertension in combination with gout by retrospective analysis data.
title_full Evaluation of the state of medical care in patients with arterial hypertension in combination with gout by retrospective analysis data.
title_fullStr Evaluation of the state of medical care in patients with arterial hypertension in combination with gout by retrospective analysis data.
title_full_unstemmed Evaluation of the state of medical care in patients with arterial hypertension in combination with gout by retrospective analysis data.
title_short Evaluation of the state of medical care in patients with arterial hypertension in combination with gout by retrospective analysis data.
title_sort evaluation of the state of medical care in patients with arterial hypertension in combination with gout by retrospective analysis data
topic hypertension
gout
urat-lowering therapy
antihypertensive drugs
url http://journals.uran.ua/index.php/2307-0404/article/view/152987
work_keys_str_mv AT apkuzmina evaluationofthestateofmedicalcareinpatientswitharterialhypertensionincombinationwithgoutbyretrospectiveanalysisdata
AT omlazarenko evaluationofthestateofmedicalcareinpatientswitharterialhypertensionincombinationwithgoutbyretrospectiveanalysisdata